high-content protein microarray

CDI can do the work for you so you can concentrate on your research. Also: high-throughput assay design and HighSpec® antibody specificity testing.

antibody development and validation

Need an antibody (and a GOOD one)? If other companies’ antibodies don't cut it on specificity, call us about our FastMAb® production service.

Monoclonal antibodies from the Protein Capture Reagents Program

Funded by NIH CDI is the program developer of low-cost, high-specificity antibodies to human proteins. ... a resource for the scientific community.

CDI Laboratories headquaters

The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible — today — the protein discoveries of tomorrow. CDI protein microarrays and related services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable clinical samples. The Company’s microarray-powered monoclonal antibodies (MAbs) and MAb-related services provide unprecedented levels of specificity. The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.